FR1399M - New drug in particular for the treatment of inflammatory and painful manifestations. - Google Patents

New drug in particular for the treatment of inflammatory and painful manifestations.

Info

Publication number
FR1399M
FR1399M FR867515A FR867515A FR1399M FR 1399 M FR1399 M FR 1399M FR 867515 A FR867515 A FR 867515A FR 867515 A FR867515 A FR 867515A FR 1399 M FR1399 M FR 1399M
Authority
FR
France
Prior art keywords
inflammatory
treatment
new drug
painful manifestations
manifestations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR867515A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR867515A priority Critical patent/FR1399M/en
Priority to FR898414A priority patent/FR28F/en
Priority to US20738862 priority patent/US3174972A/en
Priority to SE7555/62A priority patent/SE317376B/xx
Priority to CH817162A priority patent/CH424780A/en
Priority to ES279054A priority patent/ES279054A1/en
Priority to GB26511/62A priority patent/GB964143A/en
Priority to BE619997A priority patent/BE619997A/en
Application granted granted Critical
Publication of FR1399M publication Critical patent/FR1399M/en
Priority to US585763A priority patent/US3376195A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR867515A 1961-07-10 1961-07-10 New drug in particular for the treatment of inflammatory and painful manifestations. Expired FR1399M (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR867515A FR1399M (en) 1961-07-10 1961-07-10 New drug in particular for the treatment of inflammatory and painful manifestations.
FR898414A FR28F (en) 1961-07-10 1962-05-23 New drug, in particular for the treatment of inflammatory and painful manifestations.
US20738862 US3174972A (en) 1961-07-10 1962-07-03 Table ii
SE7555/62A SE317376B (en) 1961-07-10 1962-07-05
CH817162A CH424780A (en) 1961-07-10 1962-07-06 Process for the preparation of novel quinoline derivatives
ES279054A ES279054A1 (en) 1961-07-10 1962-07-09 Procedure for the preparation of new derivatives of the quinolein (Machine-translation by Google Translate, not legally binding)
GB26511/62A GB964143A (en) 1961-07-10 1962-07-10 Substituted quinolines
BE619997A BE619997A (en) 1961-07-10 1962-07-10 New quinoline derivatives and method of preparation
US585763A US3376195A (en) 1961-07-10 1966-10-11 Methods for relieving pain and inflammation with 4-(phenyl-amino)quinolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR867515A FR1399M (en) 1961-07-10 1961-07-10 New drug in particular for the treatment of inflammatory and painful manifestations.

Publications (1)

Publication Number Publication Date
FR1399M true FR1399M (en) 1962-08-17

Family

ID=39820989

Family Applications (2)

Application Number Title Priority Date Filing Date
FR867515A Expired FR1399M (en) 1961-07-10 1961-07-10 New drug in particular for the treatment of inflammatory and painful manifestations.
FR898414A Expired FR28F (en) 1961-07-10 1962-05-23 New drug, in particular for the treatment of inflammatory and painful manifestations.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR898414A Expired FR28F (en) 1961-07-10 1962-05-23 New drug, in particular for the treatment of inflammatory and painful manifestations.

Country Status (1)

Country Link
FR (2) FR1399M (en)

Also Published As

Publication number Publication date
FR28F (en) 1963-04-05

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
BE628497A (en) New compound which can be used in particular for the treatment of inflammatory and / or painful manifestations
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1399M (en) New drug in particular for the treatment of inflammatory and painful manifestations.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR1783M (en) Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1510M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.